Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin, Fludarabine, and Melphalan Conditioning for Allo-SCT in B-Cell NHL
NCT00577278Phase 2Completed
- Sponsor
- City of Hope
- Start
- Oct 2007
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in B-cell non-Hodgkin lymphoma, sponsored by City of Hope. Started Oct 2007; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00577278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577278.